Palmitoyl Tetrapeptide-7
Palmitoyl Tetrapeptide-7 (Rigin) is a lipopeptide fragment of IgG that suppresses excess IL-6, a key driver of skin inflammation and aging. Used with Matrixyl as Matrixyl 3000 to reduce puffiness.
Protocol
3–8% in topical formulations
Half-Life
N/A (topical)
Molecular Structure & Chemistry
20 residues • 315 atoms • Skeletal Formula
C105H148N26O33S3
2,038.38 g/mol
2396.988 Da
3.69
-1.07
-0.7
Amino Acid Sequence
Biological Mechanisms
Reduces skin inflammation
Observed in clinical research as a primary mechanism of action for Palmitoyl Tetrapeptide-7.
IL-6 suppression
Observed in clinical research as a primary mechanism of action for Palmitoyl Tetrapeptide-7.
Puffiness reduction
Observed in clinical research as a primary mechanism of action for Palmitoyl Tetrapeptide-7.
Synergistic anti-aging
Observed in clinical research as a primary mechanism of action for Palmitoyl Tetrapeptide-7.
Improved skin texture
Observed in clinical research as a primary mechanism of action for Palmitoyl Tetrapeptide-7.
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs